Literature DB >> 2622397

Altered virulence of a pleiotropic Staphylococcus aureus mutant with a low producibility of coagulase and other factors in mice.

K Seki1, M Ogasawara, J Sakurada, M Murai, S Masuda.   

Abstract

The virulence of a pleiotropic Staphylococcus aureus mutant with an extremely low producibility of coagulase and other factors was investigated in mouse. A mutant strain, designated as CL-1, showed the same LD50 and the same intrarenal proliferation as its parental strain, when the mutant organisms were inoculated in mice in high doses. The mutant organisms, however, showed a diminished intrarenal proliferation compared with its parental organisms in low doses. This mutant strain expressed a pleiotropic phenotype such as a concomitant reduction in the producibility of coagulase, alpha-toxin, and Panton-Valentine leucocidin. The total effect due to the reduction in producibility of various factors on the virulence of the mutant strain was investigated with studies on the bacterial resistance to the phagocytic activity of leucocytes. A possible role of coagulase and that of some other staphylococcal exoproteins in the pathogenesis of S. aureus were discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2622397     DOI: 10.1111/j.1348-0421.1989.tb03156.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

Review 1.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

2.  Staphylococcus aureus in chronic and recurrent infections.

Authors:  L Slobodníková; D Kotulová; I Zahradníková
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

3.  Targeting staphylocoagulase with isoquercitrin protects mice from Staphylococcus aureus-induced pneumonia.

Authors:  Zeyuan Gao; Yongxin Luan; Panpan Yang; Li Wang; Haitao Zhang; Shisong Jing; Lin Wang; Tiedong Wang; Dacheng Wang
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-04       Impact factor: 4.813

4.  Bovine and rabbit models for the study of a Staphylococcus aureus avirulent mutant strain, RC122.

Authors:  Elina Reinoso; Gabriel Magnano; Jose Giraudo; Aldo Calzolari; Cristina Bogni
Journal:  Can J Vet Res       Date:  2002-10       Impact factor: 1.310

5.  The Staphylococcus aureus rsbW (orf159) gene encodes an anti-sigma factor of SigB.

Authors:  E Miyazaki; J M Chen; C Ko; W R Bishai
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

6.  Dabigatran inhibits Staphylococcus aureus coagulase activity.

Authors:  Thomas Vanassche; Jan Verhaegen; Willy E Peetermans; Marc F Hoylaerts; Peter Verhamme
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

7.  Murine model of cutaneous infection with gram-positive cocci.

Authors:  C Bunce; L Wheeler; G Reed; J Musser; N Barg
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

8.  Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads.

Authors:  T Sawai; K Tomono; K Yanagihara; Y Yamamoto; M Kaku; Y Hirakata; H Koga; T Tashiro; S Kohno
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

Review 9.  Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections.

Authors:  Molly McAdow; Dominique M Missiakas; Olaf Schneewind
Journal:  J Innate Immun       Date:  2012-01-03       Impact factor: 7.349

10.  Avirulence and immunogenicity in mice of a bovine mastitis Staphylococcus aureus mutant.

Authors:  C Bogni; M Segura; J Giraudo; A Giraudo; A Calzolari; R Nagel
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.